Referred in Senate

[Congressional Bills 114th Congress] [From the U.S. Government Publishing Office] [H.R. 2820 Referred in Senate (RFS)] 114th CONGRESS 1st Session H. R. 2820 _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES September 9, 2015 Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ AN ACT To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

SECTION 1. SHORT TITLE. This Act may be cited as the ``Stem Cell Therapeutic and Research Reauthorization Act of 2015''.

SEC. 2. AMENDMENTS TO THE STEM CELL THERAPEUTIC AND RESEARCH ACT OF

SEC. 2. AMENDMENTS TO THE STEM CELL THERAPEUTIC AND RESEARCH ACT OF 2005. (a) Cord Blood Inventory.--Section 2 of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) is amended in subsection (h)-- (1) in paragraph (1)-- (A) by striking ``$23,000,000 for each of fiscal years 2011 through 2014 and''; and (B) by inserting before the period at the end the following: ``and $23,000,000 for each of fiscal years 2016 through 2020''; and (2) in paragraph (2), by striking ``2011 through 2015'' and inserting ``2015 through 2020''. (b) National Program.--Section 379B of the Public Health Service Act (42 U.S.C. 274m) is amended by striking ``2011 through 2014'' and inserting ``2016 through 2020''. Passed the House of Representatives September 8, 2015. Attest: KAREN L. HAAS, Clerk.